Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites.
Y Itzhak
Index: Life Sci. 42 , 745, (1988)
Full Text: HTML
Abstract
The pharmacological specificity of representative psychotomimetic agents such as phencyclidine (PCP) analogs, opiate benzomorphans and several antipsychotic agents was assessed for the sigma and PCP binding sites. In a series of binding experiments, in rat brain membranes, sigma and PCP binding sites were labeled with [3H]-1-[1-(3-hydroxyphenyl)cyclohexyl]piperidine [( 3H]PCP-3-OH), (+) [3H]-N-allylnormetazocine [(+) [3H]SKF 10047] and (+) [3H]-3-[3-hydroxy-phenyl]-N-(1-propyl)piperidine [(+) [3H]-3-PPP]. PCP analogs inhibit potently high affinity [3H]PCP-3-OH binding and (+) [3H]SKF 10047 binding, moderately the low affinity binding component of [3H]PCP-3-OH and very weakly (+) [3H]-3-PPP binding. (+)SKF 10047 and cyclazocine are potent to moderate inhibitors of (+) [3H]SKF 10047, high affinity [3H]PCP-3-OH and (+) [3H]-3-PPP binding, but extremely weak inhibitors of low affinity [3H]PCP-3-OH binding. The antipsychotic agents display high affinity for (+) [3H]-3-PPP binding sites, moderate affinity for (+) [3H]SKF 10047 sites and have no effect on either the high or low affinity [3H]PCP-3-OH binding. The present data further support the existence of multiple sigma and PCP binding sites.
Related Compounds
Related Articles:
2015-08-01
[Br. J. Pharmacol. 172 , 4052-65, (2015)]
1999-06-01
[J. Pharmacol. Exp. Ther. 289 , 1362, (1999)]
2000-01-28
[Eur. J. Pharmacol. 388 , 139-146, (2000)]
2011-01-07
[J. Thorac. Cardiovasc. Surg. 286 , 99-113, (2011)]
1999-06-25
[J. Biol. Chem. 274 , 18387-18392, (1999)]